TR200101801T2 - Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi. - Google Patents

Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi.

Info

Publication number
TR200101801T2
TR200101801T2 TR2001/01801T TR200101801T TR200101801T2 TR 200101801 T2 TR200101801 T2 TR 200101801T2 TR 2001/01801 T TR2001/01801 T TR 2001/01801T TR 200101801 T TR200101801 T TR 200101801T TR 200101801 T2 TR200101801 T2 TR 200101801T2
Authority
TR
Turkey
Prior art keywords
formula
compound
aminomethyl
pyrrolidine
protected
Prior art date
Application number
TR2001/01801T
Other languages
English (en)
Inventor
Yul Moon Kwang
Sup Kim Won
Hee Lee Tae
Hyok Chang Jay
Original Assignee
Lg Chemical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd. filed Critical Lg Chemical Ltd.
Publication of TR200101801T2 publication Critical patent/TR200101801T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

P1 ve P2'nin koruyucu gruplar oldugu bir formül (1) bilesiminin hazirlanmasi için, (a) P1'in formül (1) için tanimlandigi gibi oldugu bir formül (5) bilesiminin, P1'in formül(1) için tanimlandigi gibi oldugu bir formül (6) bilesimi üretmek üzere, hidrojen altinda, bir solventte, bir Raney-nikel katalistiyle tepkimesini; (b) P1 ve P2 nin formül (1) için tanimlandigi gibi oldugu bir formül (7) bilesiminin üretilmesi için amino grubunun korunmasini; ve (c) formül (1) bilesiminin üretilmesi için ikili bagin seçimli olarak indirgenmesini içeren bir proses.
TR2001/01801T 1998-03-04 1999-03-04 Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi. TR200101801T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19980007079 1998-03-04
KR1019980043636A KR100286874B1 (ko) 1998-03-04 1998-10-19 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법

Publications (1)

Publication Number Publication Date
TR200101801T2 true TR200101801T2 (tr) 2002-06-21

Family

ID=26633492

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2000/02526T TR200002526T2 (tr) 1998-03-04 1999-03-04 Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi.
TR2001/01800T TR200101800T2 (tr) 1998-03-04 1999-03-04 Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi.
TR2001/01801T TR200101801T2 (tr) 1998-03-04 1999-03-04 Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TR2000/02526T TR200002526T2 (tr) 1998-03-04 1999-03-04 Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi.
TR2001/01800T TR200101800T2 (tr) 1998-03-04 1999-03-04 Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi.

Country Status (29)

Country Link
US (1) US6307059B1 (tr)
EP (1) EP1068182B1 (tr)
JP (1) JP3374155B2 (tr)
KR (1) KR100286874B1 (tr)
CN (1) CN1149192C (tr)
AP (1) AP1305A (tr)
AT (1) ATE297379T1 (tr)
AU (1) AU742497B2 (tr)
BG (1) BG64674B1 (tr)
BR (1) BRPI9908472B8 (tr)
CA (1) CA2322540C (tr)
CZ (1) CZ301011B6 (tr)
DE (1) DE69925721T2 (tr)
EA (1) EA002499B1 (tr)
ES (1) ES2242382T3 (tr)
HU (1) HU228309B1 (tr)
ID (1) ID25901A (tr)
IL (1) IL137828A0 (tr)
IN (1) IN190979B (tr)
IS (1) IS2296B (tr)
NO (1) NO317258B1 (tr)
NZ (2) NZ506312A (tr)
OA (1) OA11482A (tr)
PT (1) PT1068182E (tr)
SK (1) SK285595B6 (tr)
TR (3) TR200002526T2 (tr)
TW (1) TW453993B (tr)
UA (1) UA71907C2 (tr)
WO (1) WO1999044991A1 (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
KR20020018560A (ko) * 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-ｚ-메톡시이미노피롤리딘의 신규 제조방법
DE60229255D1 (de) * 2001-08-02 2008-11-20 Lg Life Sciences Ltd Verfahren zur herstellung von amino-geschützten 4-aminomethylene-pyrrolidin-3-on-derivaten, gemifloxacin und deren salze
RU2004112771A (ru) * 2001-09-26 2005-10-10 Байер Фармасьютикалс Корпорейшн (US) Производные 1, 8-нафтиридина как противодиабетические средства
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
KR100515591B1 (ko) * 2003-02-12 2005-09-16 주식회사 엘지화학 4[Ｎ-(ｔ-부톡시카르보닐)아미노)메틸렌]-1-Ｎ-(ｔ-부톡시카르보닌)피롤리돈-3-온의 제조방법
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
DE102004010943A1 (de) * 2004-03-03 2005-09-29 Degussa Ag Verfahren zur Herstellung von N-geschützten 4-Ketprolinderivaten
US7185495B2 (en) * 2004-09-07 2007-03-06 General Electric Company System and method for improving thermal efficiency of dry low emissions combustor assemblies
CN104693088B (zh) * 2013-12-06 2018-01-05 常州市勇毅生物药业有限公司 一种吉米沙星侧链的制备方法
CN106349083A (zh) * 2016-08-26 2017-01-25 大连奇凯医药科技有限公司 2,4,6‑三氟苯甲胺的制备方法
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN113773240B (zh) * 2021-10-12 2022-05-31 北京阳光诺和药物研究股份有限公司 吉米沙星侧链化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309368A (en) * 1965-11-19 1967-03-14 American Cyanamid Co Substituted isoxazoles and methods of preparing the same
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
JPH0673056A (ja) * 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
EP0688772B1 (en) 1994-06-16 1999-05-06 LG Chemical Limited Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation

Also Published As

Publication number Publication date
EA002499B1 (ru) 2002-06-27
TR200002526T2 (tr) 2001-03-21
AP2000001890A0 (en) 2000-09-30
CA2322540A1 (en) 1999-09-10
IL137828A0 (en) 2001-10-31
CN1291975A (zh) 2001-04-18
EP1068182A1 (en) 2001-01-17
DE69925721T2 (de) 2006-03-23
BG104767A (en) 2001-05-31
NZ506312A (en) 2002-04-26
BR9908472B1 (pt) 2013-11-05
OA11482A (en) 2004-05-03
AU2643399A (en) 1999-09-20
US6307059B1 (en) 2001-10-23
WO1999044991A1 (en) 1999-09-10
BG64674B1 (bg) 2005-11-30
BR9908472A (pt) 2000-12-05
DE69925721D1 (de) 2005-07-14
HUP0101094A3 (en) 2001-11-28
NZ516778A (en) 2002-12-20
NO317258B1 (no) 2004-09-27
AP1305A (en) 2004-09-10
JP2002505322A (ja) 2002-02-19
IS2296B (is) 2007-10-15
JP3374155B2 (ja) 2003-02-04
TR200101800T2 (tr) 2002-04-22
KR19990076521A (ko) 1999-10-15
NO20004288D0 (no) 2000-08-25
ATE297379T1 (de) 2005-06-15
AU742497B2 (en) 2002-01-03
BRPI9908472B8 (pt) 2021-05-25
IS5600A (is) 2000-08-22
CZ301011B6 (cs) 2009-10-14
UA71907C2 (uk) 2005-01-17
PT1068182E (pt) 2005-10-31
HU228309B1 (en) 2013-03-28
SK12992000A3 (sk) 2001-11-06
TW453993B (en) 2001-09-11
SK285595B6 (sk) 2007-04-05
CZ20003109A3 (cs) 2001-07-11
EP1068182B1 (en) 2005-06-08
CA2322540C (en) 2004-11-30
ID25901A (id) 2000-11-09
CN1149192C (zh) 2004-05-12
EA200000900A1 (ru) 2001-02-26
ES2242382T3 (es) 2005-11-01
IN190979B (tr) 2003-09-06
HUP0101094A2 (hu) 2001-08-28
NO20004288L (no) 2000-10-25
KR100286874B1 (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
TR200002526T2 (tr) Korumalı bir 4-aminometil-pirrolidin-3-on hazırlama prosesi.
TR200102800T2 (tr) Yeni bileşikler.
TR199902552T2 (tr) Fungisidal triflorometilalkilamino-triazolopirimidinler.
WO2002003984A3 (en) Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
CA2369099A1 (en) Anticonvulsant derivatives useful in reducing blood glucose levels
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
TR199901874T2 (tr) 3'-n-oksit,3'-n-dimetilamin, 9-oksim eritromisin A türevleri.
CA2369095A1 (en) Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
CA2369093A1 (en) Anticonvulsant derivatives useful in lowering lipids
TR199900516T2 (tr) 6-Aminokapronitril ve heksametilendiamin'in ayni zamanli üretimi için yöntem.
TR200002237T2 (tr) Benzotiyadiazol ve türevleri
TR199902213T2 (tr) Pirazol türevleri hazirlanmasi için bir proses.
BR0115996A (pt) Sulfamidotienopirimidinas
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9911586A (pt) Processo para preparação de 3-aril-benzenofuranonas
ATE78830T1 (de) Lactamderivate, deren herstellung und deren benutzung als hypotensive mittel.
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
RS49954B (sr) Postupak za sintezu inhibitora hiv proteaze
NZ511881A (en) Anticonvulsant O-aklyl sulfamate derivatives useful in treating post traumatic stress disorder
TR200002959A2 (tr) Pirazolo [4,3-D] pirimidin -7-onlar-3-piridilsülfonun bileşikleri ve bunların ara-bağlarının preparasyon işlemi
TR200202167T2 (tr) Sitalopram hazırlamak için yöntem
TR200101040T2 (tr) ß-alanin türevi üretmek için yeni işlemler
BR9808047B1 (pt) processo para a preparação de 2-nitroguanidinas 1,3-dissubstituìdas.
GB9806409D0 (en) Processes for preparing intermediates
ZA983231B (en) Substituted benzyloxyimino compounds.